chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: A little bit of an adverse reaction but it's nothing; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (A little bit of an adverse reaction but it's nothing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (A little bit of an adverse reaction but it's nothing). At the time of the report, VACCINATION COMPLICATION (A little bit of an adverse reaction but it's nothing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.   Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Hypokinesia, Malaise, Pyrexia
Clinical narrative: Felt sick; Could not move; Fever ( 100 to 102 F ); This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt sick), HYPOKINESIA (Could not move) and PYREXIA (Fever ( 100 to 102 F )) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient was on oxygen for 2 months) in March 2020. Concurrent medical conditions included Penicillin allergy and Allergy to antibiotic.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt sick), HYPOKINESIA (Could not move) and PYREXIA (Fever ( 100 to 102 F )). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (Felt sick), HYPOKINESIA (Could not move) and PYREXIA (Fever ( 100 to 102 F )) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) 100 to 102 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported   This case was linked to MOD-2021-321083 (Patient Link).
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration date of Moderna vaccine past the BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The date that the vial was 30 days in the refrigerator was 05Sep2021. No concomitant medication was provided. No treatment medication was provided.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Medication error, Product storage error
Clinical narrative: 13 doses of Moderna vaccine were inadvertently given past the vaccine beyond-use-date (i.e. past 30 days at fridge temperature); Administration date of Moderna vaccine past the BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (13 doses of Moderna vaccine were inadvertently given past the vaccine beyond-use-date (i.e. past 30 days at fridge temperature)) and MEDICATION ERROR (Administration date of Moderna vaccine past the BUD) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (13 doses of Moderna vaccine were inadvertently given past the vaccine beyond-use-date (i.e. past 30 days at fridge temperature)) and MEDICATION ERROR (Administration date of Moderna vaccine past the BUD). At the time of the report, PRODUCT STORAGE ERROR (13 doses of Moderna vaccine were inadvertently given past the vaccine beyond-use-date (i.e. past 30 days at fridge temperature)) and MEDICATION ERROR (Administration date of Moderna vaccine past the BUD) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-320876 (Patient Link).
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Lips swell up; This spontaneous case was reported by a pharmacist and describes the occurrence of LIP SWELLING (Lips swell up) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.     No Medical History information was reported.  On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced LIP SWELLING (Lips swell up). On 20-Aug-2021, LIP SWELLING (Lips swell up) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest discomfort, Chills, Cough, Dysphonia
Clinical narrative: Tight in the chest; Cramping right at the top around my stomach; Runny nose; Dry cough; Hoarseness in her voice; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tight in the chest), ABDOMINAL PAIN UPPER (Cramping right at the top around my stomach), RHINORRHOEA (Runny nose), COUGH (Dry cough) and DYSPHONIA (Hoarseness in her voice) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Atypical angina (Atypical angina with coronary vasospasm 20 years ago), Coronary vasospasm, Norovirus infection in June 2021, Thrombus and Intestinal ischemia. Concurrent medical conditions included Tachycardia. Concomitant products included METOPROLOL for Tachycardia.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced CHEST DISCOMFORT (Tight in the chest), ABDOMINAL PAIN UPPER (Cramping right at the top around my stomach), RHINORRHOEA (Runny nose), COUGH (Dry cough), DYSPHONIA (Hoarseness in her voice), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Chills, at a dose of 1 dosage form. In 2021, RHINORRHOEA (Runny nose), COUGH (Dry cough), DYSPHONIA (Hoarseness in her voice), CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, CHEST DISCOMFORT (Tight in the chest) and ABDOMINAL PAIN UPPER (Cramping right at the top around my stomach) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) negative. On an unknown date, Heart rate: high (High) heart rate sometimes goes up to 165, but is currently around 75.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-321079 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Pyrexia, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Tight in the chest; Cramping right at the top around my stomach; Runny nose; Dry cough; Hoarseness in her voice; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tight in the chest), ABDOMINAL PAIN UPPER (Cramping right at the top around my stomach), RHINORRHOEA (Runny nose), COUGH (Dry cough) and DYSPHONIA (Hoarseness in her voice) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Atypical angina (Atypical angina with coronary vasospasm 20 years ago), Coronary vasospasm, Norovirus infection in June 2021, Thrombus and Intestinal ischemia. Concurrent medical conditions included Tachycardia. Concomitant products included METOPROLOL for Tachycardia.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced CHEST DISCOMFORT (Tight in the chest), ABDOMINAL PAIN UPPER (Cramping right at the top around my stomach), RHINORRHOEA (Runny nose), COUGH (Dry cough), DYSPHONIA (Hoarseness in her voice), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Chills, at a dose of 1 dosage form. In 2021, RHINORRHOEA (Runny nose), COUGH (Dry cough), DYSPHONIA (Hoarseness in her voice), CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, CHEST DISCOMFORT (Tight in the chest) and ABDOMINAL PAIN UPPER (Cramping right at the top around my stomach) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) negative. On an unknown date, Heart rate: high (High) heart rate sometimes goes up to 165, but is currently around 75.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-321079 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site rash
Clinical narrative: Slight reaction on the vaccine arm; Rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Slight reaction on the vaccine arm) and VACCINATION SITE RASH (Rash) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No relevant medical history was reported.     On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Slight reaction on the vaccine arm) and VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION COMPLICATION (Slight reaction on the vaccine arm) and VACCINATION SITE RASH (Rash) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was-thyroid medication ,  Blood pressure medication ,Lipid medication ,Allergy medication ,cream for the rosacea.   No treatment information was provided.   This case was linked to MOD-2021-321100 (Patient Link).
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: The patient got 2 doses of Moderna vaccine this morning within a matter of minutes; This spontaneous case was reported by a nurse and describes the occurrence of EXTRA DOSE ADMINISTERED (The patient got 2 doses of Moderna vaccine this morning within a matter of minutes) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Sep-2021, the patient experienced EXTRA DOSE ADMINISTERED (The patient got 2 doses of Moderna vaccine this morning within a matter of minutes). At the time of the report, EXTRA DOSE ADMINISTERED (The patient got 2 doses of Moderna vaccine this morning within a matter of minutes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia, Lethargy, Malaise, Nausea
Clinical narrative: Lethargic; Not himself; Nauseous; sleeping a lot for 2 days  .; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (sleeping a lot for 2 days  .), LETHARGY (Lethargic), MALAISE (Not himself) and NAUSEA (Nauseous) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     The patient's past medical history included Brain operation (affected memory).    On 09-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (sleeping a lot for 2 days  .), LETHARGY (Lethargic), MALAISE (Not himself) and NAUSEA (Nauseous). At the time of the report, HYPERSOMNIA (sleeping a lot for 2 days  .) had resolved and LETHARGY (Lethargic), MALAISE (Not himself) and NAUSEA (Nauseous) outcome was unknown.            No concomitant medication were reported.   No treatment information was provided by the reporter.   This case was linked to MOD-2021-321082, MOD-2021-321453 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Sep-2021: Follow up received contain patient's postal address, procedure as brain surgery . On 21-Sep-2021: Follow up received contain no new information.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: injection area itching; injection arm hurt a little/injection arm tender; injection area swollen; injection area red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection area itching), VACCINATION SITE PAIN (injection arm hurt a little/injection arm tender), VACCINATION SITE SWELLING (injection area swollen) and VACCINATION SITE ERYTHEMA (injection area red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was given.     On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (injection area itching), VACCINATION SITE PAIN (injection arm hurt a little/injection arm tender), VACCINATION SITE SWELLING (injection area swollen) and VACCINATION SITE ERYTHEMA (injection area red). At the time of the report, VACCINATION SITE PRURITUS (injection area itching), VACCINATION SITE PAIN (injection arm hurt a little/injection arm tender), VACCINATION SITE SWELLING (injection area swollen) and VACCINATION SITE ERYTHEMA (injection area red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants were not provided. Treatment was not given.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Rash, Rosacea, Vaccination site erythema
Clinical narrative: flared up the rosacea; rash on my opposite arm of the shot; arm that received the vaccine is "alson red like a sunburn"; it is red like a sunburn did not itched/face is red like a sunburn and feels like heat like a sunburn; my face is red like a sunburn and feels like heat like a sunburn; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (it is red like a sunburn did not itched/face is red like a sunburn and feels like heat like a sunburn), FEELING HOT (my face is red like a sunburn and feels like heat like a sunburn), ROSACEA (flared up the rosacea), RASH (rash on my opposite arm of the shot) and VACCINATION SITE ERYTHEMA (arm that received the vaccine is "alson red like a sunburn") in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     Concurrent medical conditions included Rosacea and Thyroid disorder.    On 11-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Sep-2021, the patient experienced ERYTHEMA (it is red like a sunburn did not itched/face is red like a sunburn and feels like heat like a sunburn), FEELING HOT (my face is red like a sunburn and feels like heat like a sunburn), RASH (rash on my opposite arm of the shot) and VACCINATION SITE ERYTHEMA (arm that received the vaccine is "alson red like a sunburn"). On an unknown date, the patient experienced ROSACEA (flared up the rosacea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (it is red like a sunburn did not itched/face is red like a sunburn and feels like heat like a sunburn), FEELING HOT (my face is red like a sunburn and feels like heat like a sunburn), ROSACEA (flared up the rosacea), RASH (rash on my opposite arm of the shot) and VACCINATION SITE ERYTHEMA (arm that received the vaccine is "alson red like a sunburn") had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had taken Concomitant medication namely thyroid medication in two doses, Blood pressure medication , Lipid medication , Allergy medication and cream for the rosacea for unknown indication with an unspecified date.  Patient also reported that his Rosacea condition was present before vaccination but got flared up after first dose of vaccination.   This case was linked to MOD-2021-321080 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: How long do the side effects last from the second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (How long do the side effects last from the second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (How long do the side effects last from the second shot). At the time of the report, VACCINATION COMPLICATION (How long do the side effects last from the second shot) outcome was unknown.                Concomitant medication use was unknown Treatment information was unknown
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: soreness in arm of injection; lymph node under her am is extremely swollen and extremely painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness in arm of injection) and LYMPHADENOPATHY (lymph node under her am is extremely swollen and extremely painful) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness in arm of injection) and LYMPHADENOPATHY (lymph node under her am is extremely swollen and extremely painful). At the time of the report, VACCINATION SITE PAIN (soreness in arm of injection) and LYMPHADENOPATHY (lymph node under her am is extremely swollen and extremely painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include birth control.  No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Nurse gave a Moderna COVID-19 vaccine to today 16Sep2021 that was expired 3 days ago; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nurse gave a Moderna COVID-19 vaccine to today 16Sep2021 that was expired 3 days ago) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Nurse gave a Moderna COVID-19 vaccine to today 16Sep2021 that was expired 3 days ago). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Nurse gave a Moderna COVID-19 vaccine to today 16Sep2021 that was expired 3 days ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Illness, Pyrexia
Clinical narrative: chills; Fever; Headaches; Sick for 36 hours; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for 36 hours), CHILLS (chills), PYREXIA (Fever) and HEADACHE (Headaches) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2021. Concomitant products included QUINAPRIL, PRAVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication.    On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Aug-2021, the patient experienced ILLNESS (Sick for 36 hours). On an unknown date, the patient experienced CHILLS (chills), PYREXIA (Fever) and HEADACHE (Headaches). On 10-Aug-2021, ILLNESS (Sick for 36 hours) had resolved. At the time of the report, CHILLS (chills), PYREXIA (Fever) and HEADACHE (Headaches) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-321146.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Dysstasia, Gait disturbance, Headache
Clinical narrative: can hardly stand up; arm really hurts; when took band aid off it was kind of bloody; Aches and pains in knees; light headache; higher fever, for 26-27 hours the patient has been having 100.8 F; First shot on 08Aug2021/Second shot on 15Sep2021; Patient had to grab onto things, and patient was staggering/could hardly get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Patient had to grab onto things, and patient was staggering/could hardly get out of bed), DYSSTASIA (can hardly stand up), PAIN IN EXTREMITY (arm really hurts), VACCINATION SITE HAEMORRHAGE (when took band aid off it was kind of bloody) and ARTHRALGIA (Aches and pains in knees) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048F21A and 017E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2021. Concomitant products included QUINAPRIL, PRAVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication.   On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Sep-2021, the patient experienced GAIT DISTURBANCE (Patient had to grab onto things, and patient was staggering/could hardly get out of bed). 15-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot on 08Aug2021/Second shot on 15Sep2021). On an unknown date, the patient experienced DYSSTASIA (can hardly stand up), PAIN IN EXTREMITY (arm really hurts), VACCINATION SITE HAEMORRHAGE (when took band aid off it was kind of bloody), ARTHRALGIA (Aches and pains in knees), HEADACHE (light headache) and PYREXIA (higher fever, for 26-27 hours the patient has been having 100.8 F). The patient was treated with PARACETAMOL (TYLENOL) on 15-Sep-2021 at a dose of 500 mg twice a day and ACETYLSALICYLIC ACID (ASPIRIN LOW) for Adverse event, at an unspecified dose and frequency. On 15-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot on 08Aug2021/Second shot on 15Sep2021) had resolved. At the time of the report, GAIT DISTURBANCE (Patient had to grab onto things, and patient was staggering/could hardly get out of bed), DYSSTASIA (can hardly stand up), PAIN IN EXTREMITY (arm really hurts), VACCINATION SITE HAEMORRHAGE (when took band aid off it was kind of bloody), ARTHRALGIA (Aches and pains in knees), HEADACHE (light headache) and PYREXIA (higher fever, for 26-27 hours the patient has been having 100.8 F) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.8 degree fahrenheit (High) For 26-27 hours the patient had been having 100.8 degree Fahrenheit.         This case was linked to MOD-2021-321134 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pain in extremity, Pyrexia, Vaccination site haemorrhage
Clinical narrative: can hardly stand up; arm really hurts; when took band aid off it was kind of bloody; Aches and pains in knees; light headache; higher fever, for 26-27 hours the patient has been having 100.8 F; First shot on 08Aug2021/Second shot on 15Sep2021; Patient had to grab onto things, and patient was staggering/could hardly get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Patient had to grab onto things, and patient was staggering/could hardly get out of bed), DYSSTASIA (can hardly stand up), PAIN IN EXTREMITY (arm really hurts), VACCINATION SITE HAEMORRHAGE (when took band aid off it was kind of bloody) and ARTHRALGIA (Aches and pains in knees) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048F21A and 017E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2021. Concomitant products included QUINAPRIL, PRAVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication.   On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Sep-2021, the patient experienced GAIT DISTURBANCE (Patient had to grab onto things, and patient was staggering/could hardly get out of bed). 15-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot on 08Aug2021/Second shot on 15Sep2021). On an unknown date, the patient experienced DYSSTASIA (can hardly stand up), PAIN IN EXTREMITY (arm really hurts), VACCINATION SITE HAEMORRHAGE (when took band aid off it was kind of bloody), ARTHRALGIA (Aches and pains in knees), HEADACHE (light headache) and PYREXIA (higher fever, for 26-27 hours the patient has been having 100.8 F). The patient was treated with PARACETAMOL (TYLENOL) on 15-Sep-2021 at a dose of 500 mg twice a day and ACETYLSALICYLIC ACID (ASPIRIN LOW) for Adverse event, at an unspecified dose and frequency. On 15-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot on 08Aug2021/Second shot on 15Sep2021) had resolved. At the time of the report, GAIT DISTURBANCE (Patient had to grab onto things, and patient was staggering/could hardly get out of bed), DYSSTASIA (can hardly stand up), PAIN IN EXTREMITY (arm really hurts), VACCINATION SITE HAEMORRHAGE (when took band aid off it was kind of bloody), ARTHRALGIA (Aches and pains in knees), HEADACHE (light headache) and PYREXIA (higher fever, for 26-27 hours the patient has been having 100.8 F) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.8 degree fahrenheit (High) For 26-27 hours the patient had been having 100.8 degree Fahrenheit.         This case was linked to MOD-2021-321134 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Inappropriate schedule of product administration
Clinical narrative: weak since the second dose; Received the first dose in May and the second dose in July; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak since the second dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the first dose in May and the second dose in July) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2021, the patient experienced ASTHENIA (weak since the second dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the first dose in May and the second dose in July). In July 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the first dose in May and the second dose in July) had resolved. At the time of the report, ASTHENIA (weak since the second dose) had not resolved.            No concomitant medications were reported. No treatment medications were provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Breast enlargement, Product dose omission issue, Vaginal haemorrhage, Vulvovaginal mycotic infection, Weight
Clinical narrative: did not receive the second shot; two days after taking the shot, the patient's boobs grew a lot; vaginal bleeding from  the uterus/started bleeding and that was not a good thing; vaginal yeast infections were still there ( re-occurring every 3-4 weeks); This spontaneous case was reported by a consumer and describes the occurrence of BREAST ENLARGEMENT (two days after taking the shot, the patient's boobs grew a lot), VAGINAL HAEMORRHAGE (vaginal bleeding from  the uterus/started bleeding and that was not a good thing), VULVOVAGINAL MYCOTIC INFECTION (vaginal yeast infections were still there ( re-occurring every 3-4 weeks)) and PRODUCT DOSE OMISSION ISSUE (did not receive the second shot) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal bleeding from  the uterus/started bleeding and that was not a good thing) and VULVOVAGINAL MYCOTIC INFECTION (vaginal yeast infections were still there ( re-occurring every 3-4 weeks)). On 13-Feb-2021, the patient experienced BREAST ENLARGEMENT (two days after taking the shot, the patient's boobs grew a lot). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not receive the second shot). At the time of the report, BREAST ENLARGEMENT (two days after taking the shot, the patient's boobs grew a lot) and VAGINAL HAEMORRHAGE (vaginal bleeding from  the uterus/started bleeding and that was not a good thing) outcome was unknown, VULVOVAGINAL MYCOTIC INFECTION (vaginal yeast infections were still there ( re-occurring every 3-4 weeks)) had not resolved and PRODUCT DOSE OMISSION ISSUE (did not receive the second shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Weight: weight gain of 5 pounds (High) weight gain of 5 pounds. On an unknown date, Weight: weight loss (Low) After 5 or 6 months, the weight when away like woof..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment information was provided. The patient went through tests and the physician found out that there was no cancer. These  reactions never happened to the patient before. The patient thinks that the patient got too much of the shot. The patient wants to know if the vaccine could cause any hormonal imbalances and whether the 3rd dose (dosage amount) is given the same to a man weighing 210 lbs and the same for a 1000 lb woman.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Influenza like illness, Joint swelling
Clinical narrative: Both of my legs and my stomach feel hot to the touch off and on; I have flu like symptoms; I have swelling on my left ankle; Felt very tired; I get chills; Injection site left arm is sore / injection site left arm is painful; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful) and FATIGUE (Felt very tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906 and 05E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included PARACETAMOL (ACETAMINOPHEN) for an unknown indication.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful). On 16-Sep-2021, the patient experienced FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), FATIGUE (Felt very tired) and CHILLS (I get chills). At the time of the report, FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful), FATIGUE (Felt very tired) and CHILLS (I get chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-321153.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Both of my legs and my stomach feel hot to the touch off and on; I have flu like symptoms; I have swelling on my left ankle; Felt very tired; I get chills; Injection site left arm is sore / injection site left arm is painful; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful) and FATIGUE (Felt very tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906 and 05E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included PARACETAMOL (ACETAMINOPHEN) for an unknown indication.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful). On 16-Sep-2021, the patient experienced FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), FATIGUE (Felt very tired) and CHILLS (I get chills). At the time of the report, FEELING HOT (Both of my legs and my stomach feel hot to the touch off and on), INFLUENZA LIKE ILLNESS (I have flu like symptoms), JOINT SWELLING (I have swelling on my left ankle), VACCINATION SITE PAIN (Injection site left arm is sore / injection site left arm is painful), FATIGUE (Felt very tired) and CHILLS (I get chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-321153.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: first dose > 35 days ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose > 35 days ago) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041D21A or 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose > 35 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first dose > 35 days ago) had resolved.            No concomitant medications reported. No treatment medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Muscle spasms, Urinary tract infection, Urine analysis
Clinical narrative: UTI; low back pain; back spasms; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (low back pain), MUSCLE SPASMS (back spasms) and URINARY TRACT INFECTION (UTI) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 052E21A) for COVID-19 vaccination.     The patient's past medical history included Bladder disorder (history of bladder problems).   On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Sep-2021, the patient experienced BACK PAIN (low back pain) and MUSCLE SPASMS (back spasms). On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI). The patient was treated with IBUPROFEN for Adverse event, at a dose of 800 milligram three times a day. At the time of the report, BACK PAIN (low back pain), MUSCLE SPASMS (back spasms) and URINARY TRACT INFECTION (UTI) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Urine analysis: abnormal (abnormal) Urine test shows UTI.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient called her HCP who encouraged her to come in to the clinic as she had a history of bladder problems.   She was prescribed a muscle relaxant, pain medication, and antibiotics for her symptoms. She had not yet taken these medications and still needs to get them from the pharmacist. No concomitant medication were provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: after not having her period for 4 months got her period; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (after not having her period for 4 months got her period) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced MENSTRUATION IRREGULAR (after not having her period for 4 months got her period). At the time of the report, MENSTRUATION IRREGULAR (after not having her period for 4 months got her period) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: too late for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (too late for the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.     On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (too late for the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (too late for the second dose) had resolved.            No concomitant medication reported. No treatment information was provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected, Vaccination site pain
Clinical narrative: sore right sjoulder injection site arm; after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore right sjoulder injection site arm) and THERAPEUTIC RESPONSE UNEXPECTED (after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN and INSULIN ASPART (NOVOLOG) for Diabetes, INSULIN for Diabetes mellitus.   On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021, the patient experienced VACCINATION SITE PAIN (sore right sjoulder injection site arm). In September 2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now). At the time of the report, VACCINATION SITE PAIN (sore right sjoulder injection site arm) and THERAPEUTIC RESPONSE UNEXPECTED (after thesecond dose on September 9, the patient have had no problem at all controlling diabetes and the patient stopped taking  insulin because the blood sugar gets too low now) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Blood glucose: 160 (Low) went down to 160. In September 2021, Blood glucose: 160 (Low) went down to 160. On an unknown date, Blood glucose: running between 250 to 300 (High) running between 250 to 300.         No treatment medications were reported Patient struggled to manage Type2 diabetes, walking as much as the patient could, rarely more than half a mile, and eating low sugar snacks and taking insulin shots, the FlexTouch (insulin degludec injection) at 35 units once a day, and the Novolog Flexpen (fast acting) at 20 units 3/day.  Patient feels pretty sure that it was not coincidental as there were no other changes in his lifestyle, other than the vaccine. On the previous day, the patient walked a full mile for the first time in a long time and felt confident enough. Patient believed that the vaccine worked miraculously in controlling the diabetes.   This case was linked to MOD-2021-321312 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Sep-2021: New concomitant medications added, added information in inarrative supplement.
Sex: M
Vaccine: COVID19
Symptoms: Blister, Burning sensation, Erythema, Feeling hot, Pruritus
Clinical narrative: Blisters on his hand and feet; it was all red; blisters are on fire/hand feels like burn; hot all the time; itching is coming back and forth; irritation; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blisters on his hand and feet), ERYTHEMA (it was all red), BURNING SENSATION (blisters are on fire/hand feels like burn), FEELING HOT (hot all the time) and PRURITUS (itching is coming back and forth) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (Blisters on his hand and feet), ERYTHEMA (it was all red), BURNING SENSATION (blisters are on fire/hand feels like burn), FEELING HOT (hot all the time), PRURITUS (itching is coming back and forth) and SKIN IRRITATION (irritation). The patient was treated with BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE CREAM) ongoing since an unknown date for Adverse event, at a dose of 0.05%; SILVER SULFADIAZINE for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of cream and pills. At the time of the report, BLISTER (Blisters on his hand and feet), ERYTHEMA (it was all red), BURNING SENSATION (blisters are on fire/hand feels like burn), FEELING HOT (hot all the time), PRURITUS (itching is coming back and forth) and SKIN IRRITATION (irritation) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported.   This case was linked to MOD-2021-321355 (Patient Link).